Barclays »

Eliem Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $198k 39k 5.10
2024-06-30 $18k 2.5k 7.08
2022-03-31 $24k 2.9k 8.42

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Opt Put Option (QQQ)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple Opt Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Tesla Opt Put Option (TSLA)
Ishares Tr Fund (HYG)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Broadcom (AVGO)
Visa (V)
Alphabet Opt Put Option (GOOG)

View all positions for Barclays

Top funds holding Eliem Therapeutics

RA Capital Management
Samsara BioCapital
Boxer Capital
BlackRock
Affinity Asset Advisors
T. Rowe Price Associates
Geode Capital Management
Driehaus Capital Management
Point72 Asset Management
Nan Fung Group Holdings
Northern Trust
Dr. Jeffrey R. Jay, M.D.
Monashee Investment Management
Ikarian Capital
TD Asset Management

View all funds holding Eliem Therapeutics